These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain. Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286 [TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas. Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147 [TBL] [Abstract][Full Text] [Related]
5. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro. Recht LD; Griffin TW; Raso V; Salimi AR Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin. Candiani C; Tommasi M; Fracasso G; Lorenzetti I; Adami A; Benoni G; Tridente G; Colombatti M Life Sci; 2001 Jun; 69(3):335-46. PubMed ID: 11441924 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Martell LA; Agrawal A; Ross DA; Muraszko KM Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin. Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells. Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice. Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069 [TBL] [Abstract][Full Text] [Related]
13. The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography. Sung C; Dedrick RL; Hall WA; Johnson PA; Youle RJ Cancer Res; 1993 May; 53(9):2092-9. PubMed ID: 8481911 [TBL] [Abstract][Full Text] [Related]
14. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer. Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828 [TBL] [Abstract][Full Text] [Related]
15. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors. Bjorn MJ; Groetsema G Cancer Res; 1987 Dec; 47(24 Pt 1):6639-45. PubMed ID: 3499979 [TBL] [Abstract][Full Text] [Related]
16. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins. Griffin T; Raso V Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454 [TBL] [Abstract][Full Text] [Related]
17. Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats. Harkonen S; Stoudemire J; Mischak R; Spitler LE; Lopez H; Scannon P Cancer Res; 1987 Mar; 47(5):1377-82. PubMed ID: 3493064 [TBL] [Abstract][Full Text] [Related]
18. Use of immunotoxin to inhibit proliferating human corneal endothelium. Fulcher S; Lui GM; Houston LL; Ramakrishnan S; Burris T; Polansky J; Alvarado J Invest Ophthalmol Vis Sci; 1988 May; 29(5):755-9. PubMed ID: 3259213 [TBL] [Abstract][Full Text] [Related]
19. An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Hertler AA; Schlossman DM; Borowitz MJ; Poplack DG; Frankel AE Cancer Immunol Immunother; 1989; 28(1):59-66. PubMed ID: 2783301 [TBL] [Abstract][Full Text] [Related]
20. Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate. Weiner LM; O'Dwyer J; Kitson J; Comis RL; Frankel AE; Bauer RJ; Konrad MS; Groves ES Cancer Res; 1989 Jul; 49(14):4062-7. PubMed ID: 2786751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]